BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Steinle H, Weber J, Stoppelkamp S, Große-Berkenbusch K, Golombek S, Weber M, Canak-Ipek T, Trenz SM, Schlensak C, Avci-Adali M. Delivery of synthetic mRNAs for tissue regeneration. Adv Drug Deliv Rev 2021;179:114007. [PMID: 34710530 DOI: 10.1016/j.addr.2021.114007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Li D, Liu Q, Yang M, Xu H, Zhu M, Zhang Y, Xu J, Tian C, Yao J, Wang L, Liang Y. Nanomaterials for mRNA ‐based Therapeutics: Challenges and Opportunities. Bioengineering & Transla Med 2023. [DOI: 10.1002/btm2.10492] [Reference Citation Analysis]
2 Puhl DL, Funnell JL, Fink TD, Swaminathan A, Oudega M, Zha RH, Gilbert RJ. Electrospun fiber-mediated delivery of neurotrophin-3 mRNA for neural tissue engineering applications. Acta Biomater 2023;155:370-85. [PMID: 36423820 DOI: 10.1016/j.actbio.2022.11.025] [Reference Citation Analysis]
3 Wang Y, Wang N, Yang Y, Chen Y, Zhang Z. Cellular nanomechanics derived from pattern-dependent focal adhesion and cytoskeleton to balance gene transfection of malignant osteosarcoma. J Nanobiotechnol 2022;20:499. [DOI: 10.1186/s12951-022-01713-1] [Reference Citation Analysis]
4 Shaabani E, Sharifiaghdam M, Faridi-majidi R, De Smedt SC, Braeckmans K, Fraire JC. Gene therapy to enhance angiogenesis in chronic wounds. Molecular Therapy - Nucleic Acids 2022;29:871-899. [DOI: 10.1016/j.omtn.2022.08.020] [Reference Citation Analysis]
5 Liu Y, Lu T, Liu Z, Ning W, Li S, Chen Y, Ge X, Guo C, Zheng Y, Wei X, Wang H. Six macrophage-associated genes in synovium constitute a novel diagnostic signature for osteoarthritis. Front Immunol 2022;13:936606. [DOI: 10.3389/fimmu.2022.936606] [Reference Citation Analysis]
6 Puhl DL, Mohanraj D, Nelson DW, Gilbert RJ. Designing electrospun fiber platforms for efficient delivery of genetic material and genome editing tools. Adv Drug Deliv Rev 2022;183:114161. [PMID: 35183657 DOI: 10.1016/j.addr.2022.114161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
7 Zhang Y, Hu Y, Tian H, Chen X. Opportunities and Challenges for mRNA Delivery Nanoplatforms. J Phys Chem Lett 2022;:1314-22. [PMID: 35107010 DOI: 10.1021/acs.jpclett.1c03898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Rajendran AK, Amirthalingam S, Hwang NS. A brief review of mRNA therapeutics and delivery for bone tissue engineering. RSC Adv 2022;12:8889-900. [DOI: 10.1039/d2ra00713d] [Reference Citation Analysis]
9 Yokoo H, Oba M, Uchida S. Cell-Penetrating Peptides: Emerging Tools for mRNA Delivery. Pharmaceutics 2021;14:78. [PMID: 35056974 DOI: 10.3390/pharmaceutics14010078] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
10 Machado BAS, Hodel KVS, Fonseca LMDS, Mascarenhas LAB, Andrade LPCDS, Rocha VPC, Soares MBP, Berglund P, Duthie MS, Reed SG, Badaró R. The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview. Vaccines (Basel) 2021;9:1345. [PMID: 34835276 DOI: 10.3390/vaccines9111345] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]